Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 4
1999 2
2000 5
2001 16
2002 17
2003 8
2004 16
2005 17
2006 15
2007 14
2008 12
2009 15
2010 9
2011 10
2012 10
2013 7
2014 3
2015 1
2016 1
2018 2
2019 4
2020 1
2021 2
2022 4
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 11718433

177 results
Results by year
Filters applied: . Clear all
Page 1
Risedronate: a new oral bisphosphonate.
Umland EM, Boyce EG. Umland EM, et al. Clin Ther. 2001 Sep;23(9):1409-21. doi: 10.1016/s0149-2918(01)80116-8. Clin Ther. 2001. PMID: 11589256 Review.
Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.
Rosen CJ, Hochberg MC, Bonnick SL, McClung M, Miller P, Broy S, Kagan R, Chen E, Petruschke RA, Thompson DE, de Papp AE; Fosamax Actonel Comparison Trial Investigators. Rosen CJ, et al. J Bone Miner Res. 2005 Jan;20(1):141-51. doi: 10.1359/JBMR.040920. Epub 2004 Sep 29. J Bone Miner Res. 2005. PMID: 15619680 Free article. Clinical Trial.
Bisphosphonates for osteoporosis.
[No authors listed] [No authors listed] Drug Ther Bull. 2001 Sep;39(9):68-72. doi: 10.1136/dtb.2001.39968. Drug Ther Bull. 2001. PMID: 11586803 Review.
177 results